GURU.Markets stock price, segment price, and overall market index valuation
The company's share price OPKO Health Inc.
OPKO Health is a diversified company that includes both a pharmaceutical division and one of the largest diagnostic laboratory networks in the US. Its stock price reflects both its R&D success and the volume of medical testing it conducts.
Share prices of companies in the market segment - Medanalysis
OPKO Health is a diversified healthcare company with segments in diagnostics (BioReference) and pharmaceuticals. We classify it as part of the Medanalysis sector, and the chart below reflects the dynamics of these diverse segments.
Broad Market Index - GURU.Markets
OPKO Health is a diversified biopharmaceutical and diagnostics company that operates one of the largest clinical laboratory networks. It is a component of the GURU.Markets index. The chart below represents the market. See how this holding's stock compares to the healthcare sector.
Change in the price of a company, segment, and market as a whole per day
OPK - Daily change in the company's share price OPKO Health Inc.
The volatility of OPKO Health, a diversified healthcare company, reflects the health of its diagnostics and pharmaceutical businesses. Change_co measures sensitivity to research and sales news. This metric forms the basis for healthcare sector analysis on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medanalysis
OPKO Health, Inc. is a diversified healthcare company. This chart highlights the sector's high volatility. Comparing it to OPK, with its businesses ranging from diagnostics to pharmaceuticals, helps assess how diversification impacts its stability.
Daily change in the price of a broad market stock, index - GURU.Markets
OPKO Health is a diversified healthcare company operating in diagnostics and pharmaceuticals. The chart below shows general market fluctuations, which can be used to assess how the healthcare sector, represented by OPKO, is responding to economic challenges.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization OPKO Health Inc.
OPKO is a diversified healthcare company with businesses in diagnostics and pharmaceuticals. Its annual performance represents the combined effect of these diverse businesses and contributes uniquely to the overall volatility picture.
Annual dynamics of market capitalization of the market segment - Medanalysis
OPKO Health, Inc. is a diversified healthcare company operating in diagnostics and pharmaceuticals. Its complex structure and reliance on R&D make it a unique player. The chart shows how the market values its diverse assets and its ability to commercialize its developments.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
OPKO, a diversified healthcare company, has a complex history. Its stock price reflects not so much general cycles as the success of its diagnostics and pharmaceutical divisions. The chart is a bet on management's ability to effectively manage its diverse assets and create value.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization OPKO Health Inc.
The market capitalization of OPKO, a diversified healthcare company, reflects several cycles. The monthly fluctuations on the chart are the combined effect of testing volumes in its diagnostic lab and sales of its pharmaceuticals, creating a dynamic that is difficult to analyze.
Monthly dynamics of market capitalization of the market segment - Medanalysis
OPKO Health is a diversified healthcare company engaged in both pharmaceuticals and diagnostics. Its business includes a large diagnostic laboratory and a portfolio of medications. While the chart for the medical services and testing sector provides a general overview, OPKO's valuation requires an analysis of its diverse assets and their synergies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Diversified healthcare stocks can have complex dynamics. The chart below illustrates the overall sentiment. What has a greater impact on OPKO Health: the stability of its diagnostics business or the volatility of its pharmaceutical developments?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization OPKO Health Inc.
OPKO Health, a diversified life sciences company with diagnostics (BioReference Labs) and pharmaceuticals, has a weekly stock price that reflects news from various segments. Test volumes and clinical trial results create complex and volatile dynamics.
Weekly dynamics of market capitalization of the market segment - Medanalysis
OPKO Health, as a diversified company, has a complex correlation with its sector. The chart allows you to compare its performance with the healthcare sector to see how its various segments (diagnostics, pharmaceuticals) respond to overall industry trends.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
OPKO Health is a diversified healthcare company (diagnostics, pharmaceuticals). This chart will help you assess whether diversification allows OPK shares to be more stable than the market, or whether its unique challenges and successes create their own volatility.
Market capitalization of the company, segment and market as a whole
OPK - Market capitalization of the company OPKO Health Inc.
OPKO Health's market capitalization reflects a diversified view of the healthcare industry. The chart of this holding company, which includes a large diagnostic laboratory and a pharmaceutical division, reflects a complex mix of businesses. Its performance is a barometer of how investors view this conglomerate and its prospects in various healthcare segments.
OPK - Share of the company's market capitalization OPKO Health Inc. within the market segment - Medanalysis
OPKO Health is a diversified biomedical company operating in the diagnostics (BioReference Laboratories) and pharmaceuticals sectors. Its market capitalization reflects the combined value of its various assets. The chart shows how the market values this complex company and its growth potential.
Market capitalization of the market segment - Medanalysis
OPKO Health is a diversified healthcare company focused on diagnostics and pharmaceuticals. The chart below shows the overall market capitalization of this vast sector. Its dynamics provide the backdrop against which OPKO is attempting to commercialize its diverse assets.
Market capitalization of all companies included in a broad market index - GURU.Markets
OPKO Health is a diversified biotech company with businesses in diagnostics and pharmaceuticals. Its market capitalization chart is a complex story of synergies between different businesses. Its volatile dynamics reflect both successes in some areas and setbacks in others.
Book value capitalization of the company, segment and market as a whole
OPK - Book value capitalization of the company OPKO Health Inc.
For OPKO Health, a diversified healthcare company, book value is its laboratories (BioReference) and pharmaceutical plants. The chart below is a summary of its tangible assets. Its dynamics reflect successes and failures in various segments, from diagnostics to pharmaceuticals.
OPK - Share of the company's book capitalization OPKO Health Inc. within the market segment - Medanalysis
OPKO Health is a diversified healthcare company, spanning diagnostics and pharmaceuticals. Its physical assets include a large network of clinical laboratories and manufacturing facilities. The asset share chart shows the scale of its physical assets, which support a wide range of medical services.
Market segment balance sheet capitalization - Medanalysis
OPKO Health is a diversified healthcare company, spanning diagnostics (BioReference Labs) and pharmaceuticals. This requires both laboratory equipment and R&D. The book value chart shows how these diverse, but largely tangible, assets shape its business.
Book value of all companies included in the broad market index - GURU.Markets
OPKO Health is a diversified healthcare system. Its assets include BioReference, one of the largest clinical laboratories in the US, and a pharmaceutical division with its own drugs. The chart shows the total value of this multidisciplinary medical infrastructure.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - OPKO Health Inc.
OPKO Health is a diversified healthcare company, spanning diagnostics (BioReference Labs) and pharmaceuticals. Its book value reflects its laboratories and manufacturing assets. Its market capitalization is a complex valuation of the sum of its parts, including the potential of its investigational drugs and its testing volume.
Market to book capitalization ratio in a market segment - Medanalysis
OPKO Health is a diversified life sciences company, encompassing diagnostics (BioReference Labs) and pharmaceuticals. Valuing it is difficult. The chart shows how the market values the sum of its parts, often at a discount to their book value due to its complexity and historical operating challenges.
Market to book capitalization ratio for the market as a whole
OPKO Health is a diversified biomedical company focused on diagnostics and pharmaceuticals. Its valuation is the sum of the values of its various businesses, including a large diagnostic laboratory and a portfolio of pharmaceuticals. The chart shows how the market values this complex conglomerate, which is not always easy to analyze.
Debts of the company, segment and market as a whole
OPK - Company debts OPKO Health Inc.
OPKO Health, a diversified medical diagnostics company, uses debt to finance its various businesses. This chart may reflect investments in the development of its diagnostic laboratory network, as well as in clinical trials of pharmaceuticals in its portfolio. Debt supports this multi-faceted strategy.
Market segment debts - Medanalysis
OPKO Health is a diversified life sciences company focused on diagnostics and pharmaceuticals. With a broad asset portfolio, ranging from laboratories to drugs in development, debt can be used to finance various areas. The chart shows how the company manages its complex financial structure compared to the sector.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio OPKO Health Inc.
OPKO Health is a diversified biomedical company focused on diagnostics and pharmaceuticals. Its business model encompasses both stable revenue from its diagnostic laboratory and risky pharmaceutical development. This chart shows how the company balances these areas and whether debt is used to finance unprofitable R&D projects.
Market segment debt to market segment book capitalization - Medanalysis
OPKO Health is a diversified life sciences company with divisions in diagnostics (BioReference Laboratories) and pharmaceuticals. This chart shows the overall debt burden in the sector. It helps assess how the company manages capital across its various and sometimes unrelated business segments and how this impacts its overall financial structure.
Debt to book value of all companies in the market
OPKO Health, a diversified company, has a complex structure. This chart shows the overall market leverage. It provides investors with a general macroeconomic backdrop against which to evaluate OPKO's various segments, including how its diagnostics business compares to its pharmaceutical business during different phases of the economic cycle.
P/E of the company, segment and market as a whole
P/E - OPKO Health Inc.
OPKO Health is a diversified life sciences company focused on diagnostics (BioReference Laboratories) and pharmaceuticals. This chart reflects investor sentiment about its complex structure. Its performance is driven by diagnostic testing volumes and the success of its pharmaceutical products, such as a treatment for growth hormone deficiency.
P/E of the market segment - Medanalysis
OPKO Health is a diversified company in the healthcare sector. This chart shows the average P/E for this industry. Comparing the company's P/E to this metric helps understand how the market values its complex structure (diagnostics and pharmaceuticals) and whether it sees it as more or less promising than more focused medical and biotech companies.
P/E of the market as a whole
OPKO Health is a diversified healthcare company focused on diagnostics (BioReference Laboratories) and pharmaceuticals. Its success depends on the effectiveness of both businesses. This chart reflects sentiment in the healthcare sector. It helps understand how the market views this complex entity and whether it sees synergies between the company's diagnostics and pharmaceutical businesses.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company OPKO Health Inc.
OPKO Health is a diversified life sciences company operating in diagnostics and pharmaceuticals. This chart reflects expected growth in its diagnostics business, particularly the 4Kscore prostate cancer test, and pharmaceuticals. Future profitability depends on the commercial success of its key products and developments.
%20P%2FE%20OPKO%20Health%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-OPKO-Health-Inc.&v=1772635659300 "Chart of the company's future (projected) P/E OPKO Health Inc.")
Future (projected) P/E of the market segment - Medanalysis
OPKO Health is a diversified medical diagnostics company focused on both pharmaceuticals and clinical testing. This chart shows how the market views its complex structure and future profitability. It reflects investor sentiment on its key products, such as the 4Kscore prostate cancer test, and its pharmaceutical developments.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772635659358 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
OPKO Health is a diversified biomedical company operating in diagnostics (BioReference Laboratories) and pharmaceuticals. Its success depends on both the volume of laboratory tests and the results of new drug development. The overall market environment, visible in this chart, influences healthcare budgets and investor willingness to fund biotech research.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772635659394 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit OPKO Health Inc.
OPKO Health is a diversified biomedical company with divisions in diagnostics (BioReference Laboratories) and pharmaceuticals. Its financial results are the sum of these divisions. This chart illustrates how demand for diagnostic tests and pharmaceutical sales shape the company's overall profitability.
Profit of companies in the market segment - Medanalysis
OPKO Health is a diversified life sciences company operating in diagnostics and pharmaceuticals. This chart, showing overall sector profitability, reflects the synergies between various areas of healthcare. The success of OPKO's diagnostic tests and pharmaceutical products directly impacts its contribution to the overall profitability and innovation of the industry.
Overall market profit
OPKO Health is a diversified biomedical company operating in two main segments: diagnostics (laboratory tests) and pharmaceuticals. The presence of both a stable diagnostics business and a risky but potentially highly profitable pharmaceutical business creates a unique business model that is less dependent on the success of a single product.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company OPKO Health Inc.
OPKO Health is a diversified medical biotechnology company operating in diagnostics and pharmaceuticals. The future profit forecasts you see depend on sales of its products and the testing volumes at its BioReference diagnostic laboratory. Analysts assess the dynamics of these two key business segments.
%20profit%20of%20the%20company%20OPKO%20Health%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-OPKO-Health-Inc.&v=1772635659510 "Graph of future (projected) profit of the company OPKO Health Inc.")
Future (predicted) profit of companies in the market segment - Medanalysis
OPKO Health is a diversified life sciences company operating in diagnostics (blood testing) and pharmaceuticals. This chart shows future revenue forecasts for the entire medical analytics sector. It allows you to assess how the company's combined diagnostics and pharmaceutical businesses compare against the backdrop of overall trends in personalized medicine.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772635659528 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
OPKO Health is a diversified biomedical company operating in diagnostics (testing) and pharmaceuticals. Demand for diagnostic services depends on the volume of doctor visits. This schedule is important because during periods of economic uncertainty, people may postpone preventive visits, which impacts testing volumes. The pharmaceutical segment is more stable.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772635659545 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - OPKO Health Inc.
OPKO Health is a diversified biomedical company focused on diagnostics and pharmaceuticals. This chart, plotting market capitalization against revenue, reflects the valuation of its complex business, which includes a large diagnostic laboratory and a portfolio of pharmaceuticals. It also demonstrates how investors perceive its strategy and the potential of its individual businesses.
P/S market segment - Medanalysis
OPKO Health is a diversified medical diagnostics company. It operates one of the largest clinical laboratory networks in the US and develops new pharmaceuticals and diagnostic tests. This chart reflects how the market values revenue in the healthcare sector, which helps understand how investors view the synergies between OPKO's diagnostics and pharmaceutical businesses.
P/S of the market as a whole
OPKO Health is a diversified biomedical company operating in diagnostics (BioReference Laboratories) and pharmaceuticals. This chart helps investors compare the company's revenue valuation, which combines service and product businesses, with overall market multiples.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company OPKO Health Inc.
OPKO Health is a diversified life sciences company operating in the diagnostics and pharmaceuticals sectors. This chart shows how the market values the company based on its projected future revenue from diagnostic tests and drug sales. It reflects expectations for the growth of its diagnostics division, BioReference, and the commercial success of its drugs.
%20P%2FS%20OPKO%20Health%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-OPKO-Health-Inc.&v=1772635659713 "The graph of the company's future (projected) P/S OPKO Health Inc.")
Future (projected) P/S of the market segment - Medanalysis
OPKO Health is a diversified biomedical company operating in two segments: diagnostics (BioReference Laboratories) and pharmaceuticals. The company's sector valuation reflects investors' views on the growing demand for diagnostic tests, as well as the success of its pharmaceutical products, including treatments for kidney disease and growth hormone deficiency.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772635659764 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
OPKO Health is a diversified biomedical company engaged in both pharmaceuticals and diagnostics, owning a large network of BioReference laboratories. Its success depends on demand for diagnostic tests and drug sales. This graph of investor expectations reflects their belief in the long-term growth of the healthcare sector as a whole.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772635659773 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales OPKO Health Inc.
This chart shows OPKO Health's diversified business. The company's revenue comes from two main sources: clinical diagnostic services provided by its BioReference laboratory and pharmaceutical sales. Growth in the overall revenue is dependent on testing volumes and the successful commercialization of its drugs.
Sales of companies in the market segment - Medanalysis
OPKO Health is a diversified biomedical company operating in two segments: diagnostics (one of the largest clinical laboratory networks) and pharmaceuticals (drug development). This chart reflects total revenue for the entire healthcare sector, including both diagnostic services and pharmaceutical sales.
Overall market sales
OPKO Health, Inc. is a diversified biomedical company operating in the diagnostics (BioReference Laboratories) and pharmaceuticals industries. Demand for its diagnostic services depends on testing volumes, while demand for its medications depends on medical needs. This dynamic, reflecting the overall economic situation, impacts healthcare budgets and patient affordability.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company OPKO Health Inc.
OPKO Health is a diversified biopharmaceutical and diagnostic company offering tests and pharmaceuticals. Its revenue is generated from sales of diagnostic services and pharmaceutical products. This chart reflects analysts' forecasts for demand for its key products, such as the 4Kscore prostate cancer test, and R&D progress.
%20sales%20of%20the%20company%20OPKO%20Health%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-OPKO-Health-Inc.&v=1772635660069 "Schedule of future (projected) sales of the company OPKO Health Inc.")
Future (projected) sales of companies in the market segment - Medanalysis
OPKO Health is a diversified biomedical company with divisions in diagnostics (BioReference Laboratories) and pharmaceuticals. This chart segments projected revenue by these two main areas. This allows us to assess which portion of the business, according to analysts, will be the company's primary growth driver in the future.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772635660154 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
Healthcare spending forecasts, particularly in diagnostics, which are part of the overall expectations in this chart, are important for OPKO Health. The diversified company operates in diagnostics and pharmaceuticals. Demand for its diagnostic tests and medications depends on the stability of the healthcare system and demographic trends.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772635660182 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality OPKO Health Inc.
OPKO Health is a diversified healthcare company, comprising one of the largest clinical diagnostics divisions in the US (BioReference Laboratories) and a pharmaceutical business. This chart illustrates the complex structure of its profitability. Profitability is a combination of laboratory testing volumes and pharmaceutical sales.
Market segment marginality - Medanalysis
OPKO Health is a diversified healthcare company involved in both pharmaceuticals and diagnostics. Its profitability depends on the success of its diagnostic tests and pharmaceutical sales. This chart shows the average return in the sector. It helps assess how successfully OPKO manages its diverse asset portfolio.
Market marginality as a whole
OPKO Health is a diversified life sciences company focused on diagnostics and pharmaceuticals. Its success depends on demand for diagnostic tests and the commercialization of drugs in development. This graph, reflecting the overall state of the economy, influences healthcare spending, which determines how widely tests are used and how new drugs are covered by insurance.
Employees in the company, segment and market as a whole
Number of employees in the company OPKO Health Inc.
OPKO Health, Inc. is a diversified life sciences company operating in diagnostics (BioReference Laboratories) and pharmaceuticals. This chart shows the combined headcount in both segments. Changes in headcount may reflect changes in testing volumes, such as during the pandemic, as well as progress in the development and commercialization of pharmaceuticals.
Share of the company's employees OPKO Health Inc. within the market segment - Medanalysis
OPKO Health is a diversified life sciences company focused on diagnostics (BioReference Laboratories) and pharmaceuticals. This chart shows the company's share of total employees in the medical testing and pharmaceuticals sector. This reflects the scale of its diagnostics business, which is one of the largest in the US, and its research programs.
Number of employees in the market segment - Medanalysis
OPKO Health, Inc. is a diversified life sciences company operating in diagnostics and pharmaceuticals. This chart shows employment in the medical analytics sector. The growth in the number of lab technicians and scientists in this field reflects the growing importance of accurate and rapid diagnostics for personalized medicine, a key focus for OPKO's diagnostics division.
Number of employees in the market as a whole
OPKO Health is a diversified biomedical company operating in diagnostics (BioReference Laboratories) and pharmaceuticals. Their growth depends on the volume of laboratory tests and the success of their pharmaceuticals. This overall employment pattern affects the number of people with health insurance, which drives demand for diagnostic services.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company OPKO Health Inc. (OPK)
OPKO Health is a diversified healthcare company focused on diagnostics and pharmaceuticals. It combines science-intensive research (R&D) with an operationally intensive business (diagnostic laboratories). This metric reflects this hybrid profile, balancing intellectual property with a large workforce of laboratory technicians.
%20of%20the%20company%20OPKO%20Health%20Inc.%20(OPK)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-OPKO-Health-Inc.-OPK&v=1772635660372 "Chart of market capitalization per employee (in thousands of dollars) of the company OPKO Health Inc. (OPK)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
OPKO Health (OPK) is a diversified life sciences company. They have a large clinical diagnostics business (BioReference Labs) and a pharmaceutical division. This chart helps assess how the market views their hybrid model (services + R&D).
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772635660393 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
OPKO Health is a diversified biomedical company focused on diagnostics and pharmaceuticals. Its business encompasses both drug development and the management of a large network of diagnostic laboratories. This metric reflects how the market perceives the synergy between science-intensive R&D and labor-intensive service operations within a single company.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772635660423 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company OPKO Health Inc. (OPK)
OPKO Health is a diversified healthcare company. They have both a large diagnostics business (BioReference laboratory) and a pharmaceutical division (R&D). This chart shows the combined results: their laboratory profitability divided by thousands of employees, plus R&D expenses in the pharmaceutical segment.
%20Chart%20OPKO%20Health%20Inc.%20(OPK)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-OPKO-Health-Inc.-OPK&v=1772635660442 "Company Profit Per Employee (in thousands of dollars) Chart OPKO Health Inc. (OPK)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
OPKO Health is a "diversified" "holding." They "own" a "large" "diagnostic" "laboratory" (BioReference) and "pharma" "R&D." This chart shows the benchmark for "Med-Analytics." In this sector, the benchmark is *low*. The "laboratory" "business" (tests) is a "low-margin" "B2B service," where "profit" "per" "employee" is "eaten up" by "competition."
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772635660466 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
OPKO Health is a diversified healthcare company. They have two main segments: pharmaceuticals (kidney medications, etc.) and diagnostics (one of the largest laboratories in the US, BioReference). This chart shows how a hybrid of pharmaceutical R&D and a large-scale laboratory service, requiring thousands of technicians, compares in terms of personnel efficiency.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772635660486 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee OPKO Health Inc. (OPK)
OPKO Health is a diversified biomedical company with pharmaceutical and diagnostic divisions. Revenue per employee reflects the combined performance of these divisions. The chart shows how revenue from diagnostic testing (BioReference Laboratories) and drug sales compares to the company's total headcount.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-OPKO-Health-Inc.-OPK&v=1772635660507 "Sales chart per company employee OPKO Health Inc. (OPK)")
Sales per employee in the market segment - Medanalysis
OPKO Health is a diversified life sciences company. They have a large diagnostics business (BioReference Labs) and a pharmaceutical division. This chart shows how productive their teams are. It reflects both the efficiency of their labs (test processing) and their ability to commercialize their drugs.
Sales per employee for the market as a whole
OPKO Health (OPK) is a diversified biomedical company. They have two main segments: diagnostics (BioReference lab, 4Kscore tests) and pharmaceuticals (kidney treatments, etc.). This chart reflects the performance of these two distinct businesses. The laboratory business (diagnostics) is labor-intensive but can be automated. Pharmaceuticals (drug sales) have high margins.
Short shares by company, segment and market as a whole
Shares shorted by company OPKO Health Inc. (OPK)
OPKO Health is a diversified company operating in two segments: diagnostics (BioReference laboratory) and pharmaceuticals (kidney disease treatments and others). This chart shows bearish sentiment. Skeptics point to unprofitability, declining revenue from COVID testing in their laboratory, and doubts about the commercial success of their pharmaceutical products.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-OPKO-Health-Inc.-OPK&v=1772635660580 "Short Shares Chart for the Company OPKO Health Inc. (OPK)")
Shares shorted by market segment - Medanalysis
OPKO Health (OPK) is a diversified company involved in diagnostics (BioReference lab) and pharmaceuticals (kidney treatments, growth hormone). This chart shows bets against the medical testing sector. Short positions in this segment may reflect concerns about a decline in testing volumes following the pandemic and price pressure from insurance companies.
Shares shorted by the overall market
OPKO Health is a diversified company, encompassing diagnostics (laboratories) and pharmaceuticals. Although healthcare is considered a defensive business, OPKO's business is vulnerable. When this fear indicator rises, investors fear a recession will reduce the volume of scheduled tests and medical procedures, directly impacting revenue for the diagnostics division.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator OPKO Health Inc. (OPK)
OPKO Health is a diversified company (BioReference Labs diagnostics and pharmaceuticals). The business is difficult to evaluate. A score above 70 may reflect success in one segment. A score below 30 is often associated with diagnostic problems (declining test volumes) or R&D setbacks.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-OPKO-Health-Inc.-OPK&v=1772635660632 "RSI 14 indicator chart for the company's stock OPKO Health Inc. (OPK)")
RSI 14 Market Segment - Medanalysis
OPKO Health is a diversified life sciences company. It owns BioReference (one of the largest clinical laboratories in the US) and a drug development division (for example, for kidney disease). This chart shows the overall sentiment in the medical diagnostics and testing sector. It helps understand how investors value OPKO's laboratory business relative to the rest of the industry.
RSI 14 for the overall market
OPKO Health (OPK), a diversified company (diagnostics, pharmaceuticals). This chart reflects risk appetite. In euphoria, investors are willing to believe in the conglomerate's "growth story." In panic, they see unprofitable R&D and a complex structure, preferring "clean" and profitable companies, which puts pressure on OPK shares.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast OPK (OPKO Health Inc.)
OPKO Health (OPK) is a diversified biomedical company. It owns BioReference (one of the largest diagnostic laboratories in the US) and a pharmaceutical business (Rayaldee). This chart shows the average analyst forecast, reflecting their complex assessment of the profitability of the laboratory business and the commercial success of the pharmaceuticals.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-OPK-OPKO-Health-Inc.&v=1772635660755 "A chart showing analyst consensus forecasts for the expected stock price. OPK (OPKO Health Inc.)")
The difference between the consensus estimate and the actual stock price OPK (OPKO Health Inc.)
OPKO Health (OPK) is a diversified healthcare holding company. It owns a large diagnostic laboratory (BioReference) and develops its own drugs. It is a complex and volatile company. This chart shows the difference between the consensus forecast and the price, reflecting analysts' belief in the synergies between these assets.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-OPK-OPKO-Health-Inc.&v=1772635660812 "A chart showing the difference between the consensus forecast and the actual stock price. OPK (OPKO Health Inc.)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
OPKO Health is a diversified healthcare company. It owns one of the largest commercial laboratories in the US (BioReference) and develops its own drugs. This chart shows general expectations for the medical testing sector. It reflects whether experts believe in the synergy between diagnostics and therapy.
Analysts' consensus forecast for the overall market share price
OPKO Health (OPK) is a diversified healthcare holding company (BioReference diagnostics, niche pharmaceuticals). This chart of overall market sentiment is important. Optimism = the market is willing to finance OPK's R&D projects. During a recession (pessimism), investors look to the stable but low-margin diagnostics business.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index OPKO Health Inc.
OPKO Health (OPK) is a diversified healthcare holding company. Their business includes a large diagnostic laboratory (BioReference), a pharmaceutical division, and R&D projects. This chart is a summary valuation of their complex assets. It reflects the profitability of their laboratory business (which has skyrocketed due to COVID testing) and the potential of their R&D pipeline.
AKIMA Market Segment Index - Medanalysis
OPKO Health (OPK) is a diversified healthcare holding company; the company owns two businesses: a large diagnostic laboratory (BioReference) and a pharmaceutical R&D division. This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does this hybrid (diagnostics + R&D) model (OPK) differentiate it from the average competitor?
The AKIM Index for the overall market
OPKO Health is a diversified company with interests in diagnostics (BioReference), pharmaceuticals, and veterinary medicine. This chart, which reflects the market average, provides a macro backdrop. It helps assess how OPKO, which encompasses various healthcare segments with varying cyclical patterns, compares to overall economic trends.
